INSERM (Institute National De La Sane Et De La Recherche Medicle)
INSERM (Institute National De La Sane Et De La Recherche Medicle) Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20090169540 | Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy - The present invention relates to the use of at least one Epac (Exchange Protein directly Activated by cAMP) antagonist for the manufacture of a medicament intended for the prevention or the treatment of pathologies selected from the list comprising cardiac hypertrophy, cardiac arrhythmias, valvulopathies, diastolic dysfunction, chronic heart failure, ischemic heart failure, and myocarditis. | 07-02-2009 |